Pané-Alemany, R.
Ramírez-García, I. http://orcid.org/0000-0002-1058-0577
Carralero-Martínez, A.
Blanco-Ratto, L.
Kauffmann, S.
Sánchez, E.
Article History
Received: 2 March 2020
Accepted: 14 September 2020
First Online: 28 January 2021
Ethics approval and consent to participate
: This protocol has been evaluated and approved by the Research Ethics Committee of the Vall d'Hebron University Hospital (Comité de Ética de Investigación con Medicamentos y comisión de proyectos de investigación del Hospital Universitari Vall d’Hebron) (PR(RAP)285/2018). The development of the project is based on following and respecting the bioethical principles of beneficence, nonmaleficence, autonomy, justice, dignity and privacy, the Declaration of Human Rights, the Belmont Report and the International Declaration on Bioethics and Human Rights of UNESCO. It is also grounded on the statements of the World Medical Association of Helsinki, the Deontological Code of the Association of Medical Colleges of Spain and the Deontological Code of Physiotherapists of Catalonia and Spain. All patients will be informed verbally and through an information sheet and will sign the informed consent. Participation in the study may be interrupted by the patient at any time, if desired, and without negative consequences for him. All data collected will be confidential, respecting the Spanish data protection law (LOPD Ley Orgánica 3/2018, de 5 de diciembre, de Protección de Datos Personales y garantía de los derechos digitales). Likewise, the privacy of each of the participants will be respected at all times. Only the principal investigator, the two physiotherapists and the statistical analyst will have access to the final data set. It is intended to make the results public in the form of a presentation as the doctoral thesis of the principal investigator.
: Not applicable.
: The authors declare that they have no competing interests.